Mayuresh Joshi, VP Institution of Angel Broking told CNBC-TV18, "Ashok Leyland's Q4 performance was a very dismal. So, in our opinion though we have got an accumulate rating on that stock for Rs 25-26 as our target price it depends on investors time horizon."
"If one has a structural view of two to three years one should stay invested in the stock otherwise one could exit the stock on rallies and possibly look at stocks like Aurobindo Pharma on declines or even something within the consumer discretionary like Dabur India or Emami on declines," he added. Also Read: Defence orders will help improve margins: Ashok Leyland
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
